For decades, the MedTech industry has faced numerous data and evidence challenges.
Until recently, many Regulatory, Quality, and Clinical Affairs professionals been making do with data silos, patchwork systems, and manual workflows.
With the passage of EU MDR and IVDR, manufacturers must now provide an unprecedented amount of clinical and performance data while meeting new evidence standards and transparency requirements.
What is “The Post-Market Gambit?”
Mounting compliance costs could exceed 5% of annual revenue, presenting MedTech companies with a difficult Post-Market Intelligence bridges the gap between MedTech data and decision-making with the ease of Alexa and the power of business intelligence.